Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Gazzard

Showing results (81-90 of 206) with videos related to

Pageof 21
Sort By:
AIDS (London, England)|January 25, 2003
Lack of response of anal intra-epithelial neoplasia to highly active antiretroviral therapyPaul Fox, Justin Stebbing, Simon Portsmouth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphomaJustin Stebbing, Brian Gazzard, Sundhiya Mandalia, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 19, 2008
Thyroid dysfunction and relationship to antiretroviral therapy in HIV-positive individuals in the HAART eraMark Nelson, Tom Powles, Abigail Zeitlin, et al.
Blood|April 23, 2011
Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman diseaseJustin Stebbing, Caroline Adams, Adam Sanitt, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2004
HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?Mark Bower, Tom Powles, Tom Newsom-Davis, et al.
International Journal of Cancer|December 4, 2003
Nadir B cell counts are significantly correlated with the risk of Kaposi's sarcomaJustin Stebbing, Brian Gazzard, Tom Newsom-Davis, et al.
Vascular Health and Risk Management|May 14, 2009
Prevention of atherosclerosis in patients living with HIVFerruccio De Lorenzo, Marta Boffito, Sophie Collot-Teixeira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2011
Clinical Features and Outcome in HIV-Associated Multicentric Castleman's DiseaseMark Bower, Tom Newsom-Davis, Kikkeri Naresh, et al.
AIDS (London, England)|December 4, 2004
Tetanus vaccination with IL-2 during highly active antiretroviral therapy induces sustained and pronounced specific CD4 T-cell responsesGareth A D Hardy, Nesrina Imami, Ann K Sullivan, et al.
Circulation Research|October 1, 2020
HIV Antivirals Affect Endothelial Activation and Endothelial-Platelet CrosstalkAkif A Khawaja, Kirk A Taylor, Andrew O Lovell, et al.
Pageof 21

Showing results (81-90 of 206) with videos related to

Sort By:
Pageof 21
AIDS (London, England)|January 25, 2003
Lack of response of anal intra-epithelial neoplasia to highly active antiretroviral therapyPaul Fox, Justin Stebbing, Simon Portsmouth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphomaJustin Stebbing, Brian Gazzard, Sundhiya Mandalia, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 19, 2008
Thyroid dysfunction and relationship to antiretroviral therapy in HIV-positive individuals in the HAART eraMark Nelson, Tom Powles, Abigail Zeitlin, et al.
Blood|April 23, 2011
Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman diseaseJustin Stebbing, Caroline Adams, Adam Sanitt, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 4, 2004
HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?Mark Bower, Tom Powles, Tom Newsom-Davis, et al.
International Journal of Cancer|December 4, 2003
Nadir B cell counts are significantly correlated with the risk of Kaposi's sarcomaJustin Stebbing, Brian Gazzard, Tom Newsom-Davis, et al.
Vascular Health and Risk Management|May 14, 2009
Prevention of atherosclerosis in patients living with HIVFerruccio De Lorenzo, Marta Boffito, Sophie Collot-Teixeira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2011
Clinical Features and Outcome in HIV-Associated Multicentric Castleman's DiseaseMark Bower, Tom Newsom-Davis, Kikkeri Naresh, et al.
AIDS (London, England)|December 4, 2004
Tetanus vaccination with IL-2 during highly active antiretroviral therapy induces sustained and pronounced specific CD4 T-cell responsesGareth A D Hardy, Nesrina Imami, Ann K Sullivan, et al.
Circulation Research|October 1, 2020
HIV Antivirals Affect Endothelial Activation and Endothelial-Platelet CrosstalkAkif A Khawaja, Kirk A Taylor, Andrew O Lovell, et al.
Pageof 21